Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
Signal Transduct Target Ther
.
2022 Dec 25;7(1):395.
doi: 10.1038/s41392-022-01256-9.
Authors
Rayhane Nchioua
1
,
Federica Diofano
2
,
Sabrina Noettger
1
,
Pascal von Maltitz
1
,
Steffen Stenger
3
,
Fabian Zech
1
,
Jan Münch
1
,
Konstantin M J Sparrer
1
,
Steffen Just
2
,
Frank Kirchhoff
4
Affiliations
1
Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
2
Molecular Cardiology, Department of Internal Medicine II, Ulm University, Ulm, Germany.
3
Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, Ulm, Germany.
4
Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
[email protected]
.
PMID:
36566244
PMCID:
PMC9789943
DOI:
10.1038/s41392-022-01256-9
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Myocytes, Cardiac
SARS-CoV-2*